Shop the 2027 formulary. Do not shop a vibe.

The calendar, twice

Medicare Annual Enrollment Period is 15 October through 7 December. In 2026 that window is for 2027 Part D and Medicare Advantage. Bridge itself continues through 31 December 2027, so a 2027 plan year is still inside the demonstration.

The enrollment period in autumn 2027 is the one that must survive the cliff. Families who only shop 'for the $50' in 2026 are one year late for the real problem.

What to print from each plan

Whether Wegovy (pen and pill), Foundayo, and Zepbound appear on the 2027 formulary at all; which tier; whether PA is required; which pharmacies are in network; and whether the plan is MA-PD or a standalone PDP.

A plan that is pleasant on premiums and silent on these NDCs is a plan that returns you to cash in 2028.

Do not enroll in order to 'join Bridge'

Bridge is not a plan. It is a demonstration that rides on Part D or MA-PD you already have. Switching plans can close a pharmacy you use or interrupt a Part D GLP-1 you are already filling — and a 2026 Part D GLP-1 fill generally makes you Bridge-ineligible anyway.

VitalHound does not enroll anyone in a Medicare plan and is not a broker.

Indication still chooses 2027's path

T2D, moderate-to-severe OSA, and MASH stay on Part D in 2027. Weight-management demonstration fills stay on Bridge until the sunset. Extra Help still does not attach to the $50. The $50 still does not count as TrOOP.

Cash and commercial during OE

Commercial open enrollment is a different season and a different card. Manufacturer cash (Foundayo often ~$149 at the lowest dose; Wegovy pill 4 mg $149 until 31 August 2026, then $199; maintenance often $299) remains the backup if every plan excludes the drug.

Do not sign a ~$449 telehealth bundle because a plan finder was confusing. Confusion is not a price.